Researchers Identify Genetic Correlations Across Cancer Types
Researchers have identified 15 novel loci associated with cancer and discovered genetic correlations across different cancer types.
Diagnosis & Disease Information
Antibiotics May Prevent Chemoresistance in Metastatic Pancreatic Cancer
Antibiotics may prevent bacteria-mediated chemoresistance in patients with metastatic pancreatic cancer, a new study suggests.
Pancreatic Cancer Trials Don’t Adhere to Eligibility Criteria Guidelines
Overall compliance with eligibility criteria guidelines is low for pancreatic cancer trials, a recent study suggests.
Cancer Patients in Nursing Homes More Likely to Receive Aggressive End-of-Life Care
Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.
Incidence of Pancreatic Cancer Increasing in Younger Women
Difference in average annual percentage change due to increasing incidence in Blacks, adenocarcinoma histopathological subtype, tumor location.
Precision Medicine Can Be Integrated Into Routine Cancer Care
Implementation of precision oncology recommendations has clinical utility for patients with gastrointestinal cancers.
Adjuvant Therapy Benefits Pancreatic Adenocarcinoma After Neoadjuvant Therapy, Resection
A retrospective review of records revealed a possible survival benefit for patients with PDAC treated with adjuvant therapy and surgery.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Test May Improve Early Detection of Pancreatic Cancer
The gene sequencing panel PancreaSeq can accurately classify pancreatic cysts as benign or potentially cancerous, according to researchers.
Liposomal Irinotecan Improves Upon 5-FU/LV in Refractory Pancreatic Cancer
Adding liposomal irinotecan to 5-fluorouracil and leucovorin can improve outcomes in gemcitabine-refractory, advanced pancreatic cancer, a phase 3 study suggests.
- Loading...
Loading...
Next post in Pancreatic Cancer
Loading... 
Loading...